Science Explorer Back to mapMap

Most cited papers from Royal Surrey County Hospital

What are the most cited papers from Royal Surrey County Hospital?

The most cited paper from Royal Surrey County Hospital is "Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer" (Sarah C. Darby, Marianne Ewertz, Paul McGale et al., 2013), with 4,034 citations. Next come "The repertoire of mutational signatures in human cancer" (3,854) and "Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer" (3,709).

Showing 50 of 59 papers. Every paper with more than 452 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer Sarah C. Darby, Marianne Ewertz, Paul McGale et al. · New England Journal of Medicine Open access 13 Mar 2013 4,034
2 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
3 Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf et al. · New England Journal of Medicine Open access 2 Jun 2004 3,709
4 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
5 International evaluation of an AI system for breast cancer screening Scott Mayer McKinney et al. · Nature Open access 2020 3,314
6 Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study Eric A. J. Hoste et al. · Intensive Care Medicine 10 Jul 2015 3,174
7 Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations J. Nygren, J. Thacker, F. Carli et al. · World Journal of Surgery Open access 5 Oct 2012 2,179
8 Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations: 2018 Ulf O Gustafsson et al. · World Journal of Surgery Open access 13 Nov 2018 2,140
9 Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Nicholas David James et al. · The Lancet Open access 21 Dec 2015 1,985
10 Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution Christopher Abbosh et al. · Nature Open access104 authors 25 Apr 2017 1,978
11 Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial John P. Neoptolemos et al. · The Lancet Open access 24 Jan 2017 1,953
12 Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy Nicholas David James et al. · New England Journal of Medicine Open access 3 Jun 2017 1,806
13 Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Christopher M. Nutting, James P. Morden, Kevin Joseph Harrington et al. · The Lancet Oncology Open access 14 Jan 2011 1,721
14 European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) Marko M. Babjuk, Maximilian Burger, Otakar Čapoun et al. · European Urology 9 Sep 2021 1,707
15 Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial Robert E. Mansel, Lesley J. Fallowfield, Mark W. Kissin et al. · JNCI Journal of the National Cancer Institute 2 May 2006 1,692
16 Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup on behalf of the Acute Disease Quality Initiative Workgroup 16. et al. · Nature Reviews Nephrology ReviewOpen access 26 Feb 2017 1,573
17 Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial Sean T Kehoe, Jane Hook, Matthew Guy Nankivell et al. · The Lancet 20 May 2015 1,425
18 Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial David Paul Dearnaley et al. · The Lancet Oncology Open access 22 Jun 2016 1,350
19 European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update Marko M. Babjuk, Maximilian Burger, Éva Compérat et al. · European Urology 20 Aug 2019 1,344
20 Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial Christopher Parker et al. · The Lancet Open access 21 Oct 2018 1,289
21 The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature Open access1,441 authors 5 Feb 2020 1,149
22 Mapping the human genetic architecture of COVID-19 COVID-19 Host Genetics Initiative et al. · Nature Open access3,896 authors 8 Jul 2021 1,130
23 Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations Ulf O Gustafsson, Michael J. Scott, W. Schwenk et al. · World Journal of Surgery Open access 5 Oct 2012 1,099
24 Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial Hisham Mohamed Mehanna et al. · The Lancet Open access 15 Nov 2018 1,057
25 Patterns of somatic structural variation in human cancer genomes Yilong Li et al. · Nature Open access1,411 authors 5 Feb 2020 1,005
26 European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update Morgan Rouprêt, Marko M. Babjuk, Maximilian Burger et al. · European Urology Open access 24 Jun 2020 951
27 Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Stu, David L Russell-Jones, Allan Arthur Vaag et al. · Diabetologia Open access 13 Aug 2009 835
28 Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Isidro Cortés-Ciriano et al. · Nature Genetics Open access1,407 authors 5 Feb 2020 793
29 European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update Morgan Rouprêt, Marko M. Babjuk, Éva Compérat et al. · European Urology Sep 2017 779
30 Management of febrile neutropaenia: ESMO Clinical Practice Guidelines Jean A. Klastersky, Julien de Naurois, K. V. I. Rolston et al. · Annals of Oncology Open access Sep 2016 774
31 Volumetric modulated arc therapy: a review of current literature and clinical use in practice May Teoh, Catharine H. Clark, Katie A. Wood et al. · British Journal of Radiology Open access 19 Oct 2011 767
32 Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial R.D. James, Rob Glynne‐Jones, Helen Margaret Meadows et al. · The Lancet Oncology Open access 9 Apr 2013 738
33 Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial Tom Waddell, Ian Chau, David Cunningham et al. · The Lancet Oncology Open access 17 Apr 2013 733
34 Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice Aarne Feldheiser, Omer Aziz, Giorgio Maria Baldini et al. · Acta Anaesthesiologica Scandinavica Open access 30 Oct 2015 721
35 Magnesium: physiology and pharmacology William John Fawcett, Elizabeth J. Haxby, D. A. Male · British Journal of Anaesthesia Open access Aug 1999 716
36 COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup Mitra K. Nadim et al. · Nature Reviews Nephrology ReviewOpen access 15 Oct 2020 715
37 Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Esther Rheinbay et al. · Nature Open access1,621 authors 5 Feb 2020 674
38 Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations Emmanuel Melloul, Martin Hübner, Michael J. Scott et al. · World Journal of Surgery Open access 22 Aug 2016 639
39 Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol David R. Dance, C L Skinner, Kenneth C. Young et al. · Physics in Medicine and Biology 10 Oct 2000 628
40 Genetic cause of hyperglycaemia and response to treatment in diabetes Ewan R. Pearson, Bryan J. Starkey, Roy J Powell et al. · The Lancet Oct 2003 613
41 Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial Hugo E. R. Ford, Andrea Marshall, John A. Bridgewater et al. · The Lancet Oncology Open access 9 Dec 2013 609
42 Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 Rachel F. Gabitass, Nicola E. Annels, Deborah D. Stocken et al. · Cancer Immunology Immunotherapy Open access 4 Jun 2011 575
43 Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II Gregg S Nelson, Alon D. Altman, Alpa Manchandia Nick et al. · Gynecologic Oncology Open access 4 Jan 2016 570
44 Insulin‐associated weight gain in diabetes – causes, effects and coping strategies David L Russell-Jones, Rehman Khan · Diabetes Obesity and Metabolism 15 Dec 2006 565
45 Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019 Emmanuel Melloul, Kristoffer Lassen, Didier Roulin et al. · World Journal of Surgery Open access 11 Mar 2020 541
46 Mismatch Repair Deficiency, Microsatellite Instability, and Survival Elizabeth Catherine Smyth, Andrew Charles Wotherspoon, Clare Peckitt et al. · JAMA Oncology Open access 27 Feb 2017 536
47 European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication L. von Karsa et al. · Endoscopy Open access109 authors 4 Dec 2012 536
48 European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update Morgan Rouprêt, Thomas Seisen, Alison Jane Birtle et al. · European Urology Open access 24 Mar 2023 531
49 36th International Symposium on Intensive Care and Emergency Medicine R. M. Bateman et al. · Critical Care Open access2,440 authors Apr 2016 531
50 1 Hysterectomy: a historical perspective Chris Sutton · Baillière s Clinical Obstetrics and Gynaecology Mar 1997 531

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.